Controlled document PF-012A
TLO DUO Phase 2 Master Formula
Record identification
- Document ID
- PF-012A
- Document type
- Template
- Status
- Documented
- Source
- Standardisation & Production of SIRIAM Products
Overview
PF-012A
PRODUCT FORMULA CARD
SIRIAM TLO DUO – PHASE 2 (INTEGRATION)
DOCUMENT CONTROL
Field
Product ID
Formula ID
Document
Product
Anatomical Region
Therapeutic Phase
Product Type
Standard Batch
Version
Status
Internal QR
| Value |
|---|
| SIR-TLO-002 |
| MF-012 |
| PF-012A |
| TLO DUO – Phase 2 |
| T10–L2 |
| Viscero-Autonomic Integration |
| Topical Magistral Cream |
| 100 g |
| 2.0 |
| 🔒 LOCKED |
| ☐ |
1. PRODUCT PURPOSE
Field
Clinical Objective
Anatomical Region
Primary Biological Target
Therapeutic Phase
Product Type
| Description |
|---|
| Viscero-fascial stabilisation and autonomic integration |
| T10–L2 |
| Visceral support and neurovegetative balance |
| Phase 2 – Integration |
| Topical Magistral Cream |
2. MASTER FORMULA
The formulation reflects the uploaded Phase 2 magistral fiche using the standard SQMS nomenclature.
| Code |
|---|
| Official Ingredient |
| Supplier |
| Master Qty |
| Unit |
| Phase |
| PC-001 |
| Lanette Cream FNA |
| Fagron |
| 67.00 |
| g |
| B |
| PC-002 |
| Aqua Purificata |
| Fagron |
| 18.00 |
| g |
| W |
| SC-001 |
| Magnesium Chloride |
| Fagron |
| 2.50 |
| g |
| W |
| SC-002 |
| MSM |
| — |
| 1.50 |
| g |
| W |
| OC-001 |
| Castor Oil |
| Natural Heroes |
| 3.00 |
| g |
| L |
| OC-002 |
| Jojoba Oil |
| Natural Heroes |
| 2.00 |
| g |
| L |
| SC-003 |
| D-Panthenol |
| Natural Heroes |
| 1.00 |
| g |
| W |
| SC-004 |
| Vitamin E Full Spectrum |
| Natural Heroes |
| 0.50 |
| g |
| L |
| BE-013 |
| Solidago virgaurea (A.Vogel) |
| A.Vogel |
| 0.30 |
| mL |
| C |
| BE-002 |
| Copaiba Oil |
| Aroma-Zone |
| 0.50 |
| mL |
| C |
| BE-005 |
| Nymphaea caerulea (Blue Lotus) |
| — |
| 1 drop / 300 g |
| drop |
| C |
| BE-004 |
| Bacopa monnieri |
| Mattisson |
| 0.30 |
| mL |
| C |
| SC-005 |
| Silicea Gel (+1 drop Silicea D8) |
| — |
| 2.00 |
| g |
| C |
| AC-002 |
| Betaine (TMG) |
| — |
| 0.30 |
| g |
| W |
| CL-001 |
| Sea Buckthorn Oil (optional) |
| — |
| 1 |
| drop |
| C |
| PR-001 |
| Cosgard 221 |
| Aromantic |
| 0.70 |
| g |
| C |
3. MANUFACTURING WORKFLOW
Standard SQMS Lanette Manufacturing Workflow (SOP-001), including Betaine in the water phase for Phase 2.
4. QUALITY CONTROL
Standard SQMS Quality Control checklist.
5. BATCH RELEASE
Standard SQMS Batch Release form.
6. CLINICAL APPLICATION
Field
Anatomical Region
Primary Zone
Secondary Zone
Additional Zone
Additional Projection
Frequency
Weeks 1–2
Week 3
Week 4
Week 5
Relapse
Treatment schedule follows the magistral protocol.
| Value |
|---|
| T10–L2 |
| Lower abdomen |
| Flanks |
| Paravertebral T10–L2 |
| Iliac crest |
| 1–2× daily |
| TLO-1 |
| Morning TLO-2 / Evening TLO-1 |
| TLO-2 |
| TLO-2 (evening) |
| 3–5 days TLO-1 |
Related documents
Platform modules